N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide

C25H23F3N4O5 — CID 162437928

IUPACN-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide
SMILESCCn1nccc(N2C[C@@H](c3ccc(OC)cc3)C(NC(=O)c3ccc(OC(F)(F)F)cc3)C2=O)c1=O
InChIInChI=1S/C25H23F3N4O5/c1-3-32-23(34)20(12-13-29-32)31-14-19(15-4-8-17(36-2)9-5-15)21(24(31)35)30-22(33)16-6-10-18(11-7-16)37-25(26,27)28/h4-13,19,21H,3,14H2,1-2H3,(H,30,33)/t19-,21?/m0/s1
InChIKeyJPXJZUXQGBUFCH-ZQRQZVKFSA-N
MW516.48 g/mol
LogP3.10
Rot. Bonds7

About N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide

N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide (PubChem CID 162437928) has the molecular formula C25H23F3N4O5 and a molecular weight of 516.48 g/mol. Its IUPAC name is N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide.

Molecular Properties

Compound NameN-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide
PubChem CID162437928
Molecular FormulaC25H23F3N4O5
Molecular Weight516.48 g/mol
Exact Mass516.16
IUPAC NameN-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide
SMILESCCn1nccc(N2C[C@@H](c3ccc(OC)cc3)C(NC(=O)c3ccc(OC(F)(F)F)cc3)C2=O)c1=O
InChIInChI=1S/C25H23F3N4O5/c1-3-32-23(34)20(12-13-29-32)31-14-19(15-4-8-17(36-2)9-5-15)21(24(31)35)30-22(33)16-6-10-18(11-7-16)37-25(26,27)28/h4-13,19,21H,3,14H2,1-2H3,(H,30,33)/t19-,21?/m0/s1
InChIKeyJPXJZUXQGBUFCH-ZQRQZVKFSA-N
XLogP3.10
TPSA102.76 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500516.48
LogP ≤ 53.10
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide?
The IUPAC name of N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide (CID 162437928) is N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide.
What is the SMILES notation for N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide?
The canonical SMILES for N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide is CCn1nccc(N2C[C@@H](c3ccc(OC)cc3)C(NC(=O)c3ccc(OC(F)(F)F)cc3)C2=O)c1=O.
What is the InChIKey of N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide?
The InChIKey is JPXJZUXQGBUFCH-ZQRQZVKFSA-N. The full InChI is InChI=1S/C25H23F3N4O5/c1-3-32-23(34)20(12-13-29-32)31-14-19(15-4-8-17(36-2)9-5-15)21(24(31)35)30-22(33)16-6-10-18(11-7-16)37-25(26,27)28/h4-13,19,21H,3,14H2,1-2H3,(H,30,33)/t19-,21?/m0/s1.
What are the key properties of N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide?
N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide has a molecular weight of 516.48 g/mol, XLogP of 3.10, 7 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4R)-1-(2-ethyl-3-oxopyridazin-4-yl)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-4-(trifluoromethoxy)benzamide is sourced from PubChem (CID 162437928), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).